Cerebral Blood Flow and the Effects of Inhalation Agents

PART 1: CEREBRAL BLOOD FLOW - PHYSIOLOGY AND REGULATION

Normal Values

• Overall CBF: ~50 mL/100 g/min at PaCO₂ of 40 mmHg
• Gray matter: ~80 mL/100 g/min; White matter: ~20 mL/100 g/min
• Total CBF in adults: ~750 mL/min (15-20% of cardiac output)

Cerebral Perfusion Pressure (CPP)

• Normal CPP: 80-100 mmHg
• ICP is normally <10 mmHg, so CPP is mainly MAP-dependent
• CPP <50 mmHg: EEG slowing
• CPP 25-40 mmHg: flat EEG
• CPP <25 mmHg: irreversible brain damage

Regulation of Cerebral Blood Flow

1. Cerebral Autoregulation

• Response is rapid (10-60 seconds)
• In chronically hypertensive patients, the autoregulatory curve shifts rightward

2. CO₂ Reactivity (Most Important Extrinsic Factor)

• Flow changes ~1-2 mL/100 g/min per 1 mmHg change in PaCO₂
• Mechanism: CO₂ freely crosses the blood-brain barrier, alters CSF/brain tissue pH, and changes vascular tone
• Hypercapnia → vasodilation → ↑CBF
• Hypocapnia (hyperventilation) → vasoconstriction → ↓CBF (exploited clinically to lower ICP)
• Effect diminishes after 24-48 hrs as CSF HCO₃⁻ adjusts

3. Oxygen Tension

4. Temperature

5. Neurovascular Coupling (Flow-Metabolism Coupling)

6. Viscosity

PART 2: EFFECTS OF INHALATION AGENTS ON CEREBRAL BLOOD FLOW

General Principle

A. Volatile Agents (Halothane, Isoflurane, Desflurane, Sevoflurane)

1. Cerebral Metabolic Rate (CMR / CMRO₂)

• Isoflurane → greatest maximal depression (up to 50% reduction), can cause isoelectric EEG at clinically tolerated doses
• Desflurane and Sevoflurane → similar depression to isoflurane (~50%)
• Halothane → least effect (≤25% reduction)
• No further CMR reduction occurs beyond the dose that renders the EEG isoelectric

2. Cerebral Blood Flow (CBF) - Comparative Effects

• At >1 MAC, nearly abolishes cerebral autoregulation
• Increase in CBF is generalized throughout all brain regions
• The increase in CBF despite a falling CMR is termed "luxury perfusion"

3. Effect on Cerebral Autoregulation

• Low dose: partial impairment (autoregulation plateau preserved but narrowed)
• High dose: autoregulation nearly abolished; CBF becomes pressure-dependent

4. CO₂ Reactivity

• Hyperventilation (↓PaCO₂) can abolish or blunt the initial increases in CBF caused by volatile agents
• Key difference for halothane: Hyperventilation must be initiated before halothane administration to prevent halothane-induced CBF increases. Once halothane has been given, adding hyperventilation is less effective.
• For isoflurane, desflurane, and sevoflurane: simultaneous hyperventilation can prevent increases in CBF and ICP

5. Cerebral Blood Volume and ICP

• Increases in cerebral blood volume (10-12%) generally parallel increases in CBF
• This expansion can markedly elevate ICP in patients with reduced intracranial compliance (e.g., brain tumors, head injury)
• Hypocapnia can blunt the increase in cerebral blood volume

6. Altered Flow-Metabolism Coupling ("Luxury Perfusion" vs. "Steal")

• CMR decreases, but CBF increases → CBF exceeds metabolic demand = "luxury perfusion"
• In global ischemia: potentially beneficial
• In focal ischemia: potentially detrimental - volatile agents increase flow in normal brain but NOT in ischemic areas (where arterioles are already maximally dilated). This can redistribute flow away from ischemic areas = "cerebrovascular steal"

7. CSF Dynamics

• Halothane: impedes CSF absorption, minimally reduces formation → unfavorable for raised ICP
• Isoflurane: facilitates CSF absorption → more favorable effect on CSF dynamics

8. Sevoflurane - Special Considerations

• Has no noteworthy adverse effects on cerebral physiology at normal CO₂ and BP
• High concentrations (1.5-2.0 MAC), sudden increase in concentration, especially in females, and/or hypocapnia can trigger EEG abnormalities with epileptiform features - though clinical significance remains debated
• The question of sevoflurane in epilepsy patients remains unsettled

B. Nitrous Oxide (N₂O)

• Alone: causes cerebral vasodilation, potentially increases ICP
• Combined with IV agents (e.g., propofol, opioids): minimal effects on CBF, CMR, and ICP
• Combined with volatile agents: can further increase CBF above the volatile agent alone
• The final effect on CBF depends heavily on the context and co-administered agents

Clinical Summary Table

Key Clinical Points for Neuroanaesthesia

1. Avoid halothane in neurosurgery or patients with raised ICP - it causes the greatest CBF increase and ICP rise
2. Hyperventilation before induction is the most reliable strategy to prevent inhalation agent-induced CBF increases
3. Sevoflurane or isoflurane at low concentrations (<1 MAC) with normocapnia are the preferred volatile agents in neurosurgery when total IV anaesthesia is not used
4. CO₂ reactivity is preserved with all volatile agents - hyperventilation can always be used to counteract CBF increases
5. "Cerebrovascular steal" is a theoretical concern in focal ischemia with volatile agents; IV agents (barbiturates, propofol) produce reverse steal (preferential flow toward ischemic areas)

Cerebral Blood Flow and the Effects of Inhalation Agents

PART 1: CEREBRAL BLOOD FLOW - PHYSIOLOGY AND REGULATION

Normal Values

• Overall CBF: ~50 mL/100 g/min at PaCO₂ of 40 mmHg
• Gray matter: ~80 mL/100 g/min; White matter: ~20 mL/100 g/min
• Total CBF in adults: ~750 mL/min (15-20% of cardiac output)

Cerebral Perfusion Pressure (CPP)

• Normal CPP: 80-100 mmHg; Normal ICP: <10 mmHg
• CPP <50 mmHg: EEG slowing
• CPP 25-40 mmHg: flat EEG
• CPP <25 mmHg sustained: irreversible brain damage

Regulation of CBF

1. Cerebral Autoregulation

• The plateau represents the autoregulatory range where CBF stays ~50 mL/100 g/min regardless of MAP
• Below the lower limit (~60 mmHg): CBF falls passively with MAP → ischemia
• Above the upper limit (~150-160 mmHg): CBF rises with MAP → forced vasodilation, breakdown of blood-brain barrier, cerebral edema and hemorrhage
• In chronic hypertension: the plateau shifts right; the lower limit may be at MAP ~80-100 mmHg, so these patients cannot safely tolerate "normal" hypotension during anesthesia

2. CO₂ Reactivity (Most Important Extrinsic Factor)

• Mechanism: CO₂ freely crosses the blood-brain barrier, alters CSF pH, and changes vascular tone
• Effect diminishes after 24-48 hrs as CSF HCO₃⁻ compensates

3. Oxygen Tension

4. Temperature

5. Viscosity

PART 2: EFFECTS OF INHALATION AGENTS ON CBF

General Principle

A. Volatile Agents (Halothane, Isoflurane, Desflurane, Sevoflurane)

1. CMR (CMRO₂)

2. CBF - Comparative Effects

3. Autoregulation

4. CO₂ Reactivity

• Hyperventilation can blunt or abolish volatile agent-induced CBF increases
• Halothane exception: hyperventilation must be started before halothane is given to be effective. Once halothane is established, hyperventilation alone cannot fully reverse the CBF increase.
• For isoflurane, desflurane, sevoflurane: simultaneous hyperventilation effectively prevents CBF and ICP rises.

5. Cerebral Blood Volume and ICP

• Blood volume increases 10-12% parallel to CBF increases
• Can markedly elevate ICP in patients with poor intracranial compliance (trauma, tumors)
• Hypocapnia blunts this blood volume expansion

6. Luxury Perfusion vs. Cerebrovascular Steal

• CMR ↓ but CBF ↑ → supply exceeds demand = "luxury perfusion"
• In global ischemia: potentially beneficial
• In focal ischemia: volatile agents increase flow in normal tissue but not ischemic areas (maximally dilated already) → "steal" of blood away from ischemic zones

7. CSF Dynamics

• Halothane: impedes CSF absorption → unfavorable for raised ICP
• Isoflurane: facilitates CSF absorption → more favorable

8. Sevoflurane - Special Note

B. Nitrous Oxide (N₂O)

Clinical Summary Table

Key Clinical Points

1. Avoid halothane in neurosurgery or raised ICP - causes maximum CBF and ICP rise
2. Hyperventilate before induction with halothane to prevent CBF surge; with others, simultaneous hyperventilation suffices
3. Sevoflurane or low-dose isoflurane (<1 MAC) with normocapnia are preferred volatile agents in neuroanaesthesia
4. CO₂ reactivity is always preserved with volatile agents - hyperventilation is reliably effective
5. Volatile agents cause steal in focal ischemia; IV barbiturates/propofol cause inverse steal (redistribute flow toward ischemic areas)

Cerebral Autoregulation

Definition

The Autoregulation Curve

Key Parameters of the Curve

Important contemporary view (Miller's Anesthesia): The classical autoregulatory plateau is wider and the LLA higher than originally described by Lassen. There is considerable inter-individual variability in the lower limit, upper limit, width, and slope of the plateau. The LLA in most humans is not less than 70 mmHg.

Diagram Explanation

1. Zone A (below lower limit, CPP <60 mmHg): Arterioles are maximally dilated. Vasomotor capacity exhausted. CBF falls passively with falling CPP → ischemia
2. Zone B (plateau, CPP 60-150 mmHg): Reactive arteriolar tone adjusts. ↓CPP → vasodilation; ↑CPP → vasoconstriction. CBF stays constant
3. Zone C (above upper limit, CPP >150 mmHg): Arterioles are maximally constricted. Beyond capacity → forced vasodilation → disruption of blood-brain barrier → cerebral edema, hemorrhage, hypertensive encephalopathy

Mechanisms of Autoregulation

1. Myogenic Mechanism

• The Bayliss effect: smooth muscle in cerebral arteriolar walls contracts in response to increased transmural pressure (stretch-induced contraction) and relaxes when pressure falls
• This is the primary rapid-response mechanism, accounting for much of the short-term autoregulation
• Acts within seconds

2. Metabolic Mechanism

• When MAP falls and CBF drops, local accumulation of metabolic byproducts (CO₂, H⁺, adenosine, K⁺, lactate) causes vasodilation, restoring flow
• When flow is excessive, washout of these metabolites leads to vasoconstriction
• This mechanism links autoregulation to neurovascular coupling (flow-metabolism matching)

3. Neurogenic Mechanism

• Intracranial vessels are innervated by:
  • Sympathetic (noradrenergic): vasoconstriction - provides protection during acute hypertension by limiting flow transmission
  • Parasympathetic (cholinergic): vasodilation
• Intense sympathetic stimulation shifts the autoregulatory curve rightward, protecting against hypertensive surges
• Sympathetic nerves also reduce vasodilatory capacity during hypotension

Cerebral Perfusion Pressure (CPP) and Autoregulation

• Autoregulation is driven by CPP, not MAP alone
• Normal CPP: 80-100 mmHg; Normal ICP: <10 mmHg
• In pathological states (raised ICP), autoregulation limits shift and the curve narrows

Static vs Dynamic Autoregulation

Modification of the Autoregulation Curve

Chronic Hypertension

• The brain adapts to higher "normal" pressures
• The hypertensive patient is at ischemia risk at "normal" blood pressures (MAP 70-80 mmHg) that a normotensive patient tolerates easily
• Long-term antihypertensive therapy can restore the curve toward normal

Conditions That Impair Autoregulation

Effect of Anesthetics on Autoregulation

Volatile Agents

• Sevoflurane preserves autoregulation up to ~1 MAC
• At high doses of any volatile agent, CBF becomes pressure-passive (as in Zone A/C on the diagram)

IV Agents

• Barbiturates, propofol, etomidate: decrease CMR and CBF; autoregulation preserved
• Opioids, benzodiazepines: minimal impairment; autoregulation largely preserved
• Ketamine: increases CMR and CBF modestly; autoregulation effects variable
• Vasopressors (phenylephrine, norepinephrine, ephedrine): no direct effect on autoregulation; affect CBF only via MAP

Clinical Significance of Autoregulation

1. Head injury / Raised ICP: In severe TBI, loss of autoregulation means any rise in MAP directly raises CBF and ICP - target CPP of 60-70 mmHg is recommended. Any fall in MAP leads directly to ischemia.
2. Neuroanaesthesia: Choice of agent, maintaining normocarbia, and avoiding hypotension within autoregulatory limits are the cornerstones of neuroprotection.
3. Controlled hypotension: The lower limit of autoregulation defines the safe lower boundary for induced hypotension. In hypertensive patients, this limit may be at a much higher MAP.
4. Intraoperative hypotension: When cardiac output is also low (e.g., haemorrhage), both MAP and CO fall simultaneously, further compromising CBF. Ephedrine (maintains/increases CO + MAP) may be preferable to pure vasoconstrictors like phenylephrine (which can reduce CO by increasing afterload).
5. Monitoring autoregulation: The Pressure Reactivity Index (PRx) - correlation between slow-wave arterial BP and ICP oscillations - can be continuously monitored. PRx near +1 = pressure-passive (lost autoregulation); PRx near 0 or negative = intact autoregulation. Used in neurocritical care to guide individualized CPP targets.

Summary